Please login to the form below
Asthma UK
This page shows the latest Asthma UK news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
An estimated 98, 000 patients with severe uncontrolled asthma may be eligible for the new treatment. ... Tom Keith-Roach, president of AZ UK, said: “This is an important step towards [Tezspire] being considered for use in the treatment of eligible UK
Latest news
-
AstraZeneca’s mild combination asthma reliever approved in UK
Ian Pavord, professor of respiratory medicine at the University of Oxford said: “In the UK, asthma attacks remain a major burden in patients diagnosed with mild asthma and these are driven ... 200/6 as an important new treatment option for patients
-
Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use
News from pharma, biotech and healthcare. Limited NICE approval for AZ’s asthma drug Fasenra. ... However, the UK's cost-effectiveness watchdog says the drug should only be used in limited circumstances for eosinophilic asthma, when usual therapies
-
Six new national standards are launched across UK
The UK is welcoming a new set of national standards this coming year, which are designed to improve the quality and consistency of public involvement in research. ... The standards will be launched across ten pilot sites in the UK including Asthma UK
-
NICE backs Teva's Cinqaero for severe asthma
Teva's interleukin-5 (IL-5) inhibitor should be made available to patients under the NHS as an add-on therapy for patients with for severe eosinophilic asthma, says the ... Kay Boycott, chief executive of medical charity Asthma UK, welcomed the decision.
-
NICE recognises Smartinhaler as best practice for asthma care
According to Asthma UK's Annual Asthma Survey 2016 report, emergency hospital admission is 23 times more expensive than an asthma review, with the annual cost of asthma care in the ... It is shocking that [according to Asthma UK's report] 82% of UK
More from news
Approximately 3 fully matching, plus 19 partially matching documents found.
Latest from PMHub
-
Why is behaviour change so difficult? By Patrick Ladbury, Communications Manager at the National Social Marketing Centre.
Prior to The NSMC, Patrick worked in the voluntary sector for ten years, initially in fundraising with Barnardos and VSO, and then at Asthma UK leading their Children and Young
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023
- Pfizer reports positive results for elranatamab in multiple myeloma
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Adaptive innovation
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- Navigating patients step by step on their clinical trial journey
No results were found
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
